Company Description

Profusa, Inc. develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States.

It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery.

The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid.

Profusa, Inc. is based in Berkeley, California.

Profusa, Inc.

Country	United States
Founded	2009
Industry	Medical Devices
Sector	Healthcare
Employees	15
CEO	Ben Hwang

Contact Details

Address: 626 Bancroft Way, Suite A Berkeley, California 94710 United States
Phone	925 997 6925
Website	profusa.com

Stock Details

Ticker Symbol	PFSA
Exchange	NASDAQ
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0001859807
CUSIP Number	74319X207
ISIN Number	US74319X2071
Employer ID	86-3437271
SIC Code	3841

Key Executives

Name	Position
Dr. Ben Chung-Bin Hwang Ph.D.	Chief Executive Officer and Chairman
William McMillan	Co-founder, Chief Scientific Officer and Head of Research
David Icke	Head of Digital Health Business
Sean Givens	Head of Government Business
Phil Constantinou	Head of Software and Data Science

Latest SEC Filings

Date	Type	Title
Feb 17, 2026	EFFECT	Notice of Effectiveness
Feb 17, 2026	EFFECT	Notice of Effectiveness
Feb 17, 2026	424B3	Prospectus
Feb 17, 2026	S-1/A	[Amend] General form for registration of securities under the Securities Act of 1933
Feb 13, 2026	8-K	Current Report
Feb 13, 2026	S-1/A	[Amend] General form for registration of securities under the Securities Act of 1933
Feb 13, 2026	S-1	General form for registration of securities under the Securities Act of 1933
Feb 10, 2026	424B3	Prospectus
Feb 10, 2026	424B3	Prospectus
Feb 10, 2026	424B3	Prospectus

View All SEC Filings